Cargando…
Loss of DNA mismatch repair proteins in prostate cancer
Recent studies have suggested an increased risk of prostate cancer in men with Lynch syndrome driven by germline mutations in mismatch repair (MMR) genes. However, the incidence and clinical implication of MMR deficiency in sporadic prostate cancers remain poorly understood. We immunohistochemically...
Autores principales: | Sharma, Meenal, Yang, Zhiming, Miyamoto, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220555/ https://www.ncbi.nlm.nih.gov/pubmed/32384491 http://dx.doi.org/10.1097/MD.0000000000020124 |
Ejemplares similares
-
Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
por: Sharma, Meenal, et al.
Publicado: (2019) -
The application of IL-10 and TNF-α in expressed prostatic secretions and prostatic exosomal protein in urine in the diagnosis of patients with chronic prostatitis
por: Yin, Lianli, et al.
Publicado: (2019) -
Prostate tuberculosis mimicking prostate cancer: Case report and literature review
por: Li, Yu, et al.
Publicado: (2023) -
The effect of varicocele repair for sperm DNA fragmentation: A protocol for systematic review and meta-analysis
por: Yao, Hangyu, et al.
Publicado: (2020) -
Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies
por: Dai, Xiaoyu, et al.
Publicado: (2016)